Clinical Trial Update: Tailoring Obesity Treatment Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial titled 'Tailoring Obesity Treatment' sponsored by Esbjerg Hospital – University Hospital of Southern Denmark has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prediabetes

Snippet

Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark | Conditions: Obesity, Appetite Regulation | Phase 2, Phase 3 | Status: WITHDRAWN